BioLineRx Raises $3.75M to Advance Oncology Pipeline
TEL AVIV, Israel, Aug 28, 2026 BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on therapies for oncology and rare...
Capital for New Therapy
Revier Therapeutics Launches with €6M Cardiometabolic Funding
HEIDELBERG, Germany — August 25, 2026 Revier Therapeutics has officially launched operations following the closing of a €6 million...
Insilico Medicine Gains MSCI Global Small Cap Index Inclusion
Cambridge, Massachusetts, August 17, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced...
Mironid Raises $46 Million to Advance ADPKD Therapy
Glasgow, Scotland, August 5, 2026 Mironid has successfully raised $46 million in a Series B financing round to accelerate...
AsymBio Secures $184 Million to Expand Global CDMO Growth
Shanghai, China, August 4, 2026 AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem...
CND Life Sciences Secures Growth Funding for Syn-One Test
Scottsdale, Arizona & Boca Raton, Florida, August 4, 2026 CND Life Sciences has announced the successful completion of a...
Trace Biosciences and Axogen Advance Nerve Trace Technology
PORTLAND, Ore., July 29, 2026 Trace Biosciences, Inc. has secured a strategic investment from Axogen, Inc. to accelerate clinical...
Victory Square Updates Hydreight After FDA Peptide Panel Vote
VANCOUVER, BC, July 29, 2026 Victory Square Technologies Inc. has provided an update on Hydreight Technologies and its broader...
Ratio Therapeutics Raises $70 Million to Advance Radiotherapeutics
BOSTON, July 31, 2026 Ratio Therapeutics announced the successful closing of a $70 million Series C financing, increasing the...
CORE Biomedicine Secures $21M Series A Funding
BOSTON, TOKYO and SUZHOU, July 28, 2026 CORE Biomedicine, a biotechnology company advancing lineage-based precision oncology therapeutics, has announced...